| Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. DE Gomez, DF Alonso, H Yoshiji, UP Thorgeirsson European journal of cell biology 74 (2), 111-122, 1997 | 2275 | 1997 |
| Deregulation of the signaling pathways controlling urokinase production: its relationship with the invasive phenotype JA Aguirre Ghiso, DF Alonso, EF Farías, DE Gomez, E Bal de Kier Joffè European journal of biochemistry 263 (2), 295-304, 1999 | 242 | 1999 |
| Telomere structure and telomerase in health and disease DE Gomez, RG Armando, HG Farina, PL Menna, CS Cerrudo, ... International journal of oncology 41 (5), 1561-1569, 2012 | 235 | 2012 |
| Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer HG Farina, M Pomies, DF Alonso, DE Gomez Oncology reports 16 (4), 885-891, 2006 | 197 | 2006 |
| Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2) SE Perea, O Reyes, Y Puchades, O Mendoza, NS Vispo, I Torrens, ... Cancer research 64 (19), 7127-7129, 2004 | 196 | 2004 |
| Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis DF Alonso, HG Farina, G Skilton, MR Gabri, MS De Lorenzo, DE Gomez Breast cancer research and treatment 50, 83-93, 1998 | 174 | 1998 |
| Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: report of a phase I trial E Neninger, RM Díaz, A de La Torre, R Rives, A Díaz, G Saurez, ... Cancer Biology & Therapy 6 (2), 145-150, 2007 | 158 | 2007 |
| CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo SE Perea, O Reyes, I Baladron, Y Perera, H Farina, J Gil, A Rodriguez, ... Molecular and cellular biochemistry 316, 163-167, 2008 | 125 | 2008 |
| Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells HG Farina, DR Bublik, DF Alonso, DE Gomez Clinical & experimental metastasis 19, 551-560, 2002 | 122 | 2002 |
| Cancer vaccines: an update with special focus on ganglioside antigens RJ Bitton, MD Guthmann, MR Gabri, AJL Carnero, DF Alonso, L Fainboim, ... Oncology Reports 9 (2), 267-276, 2002 | 122 | 2002 |
| Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer AM Scursoni, L Galluzzo, S Camarero, J Lopez, F Lubieniecki, C Sampor, ... Journal of Immunology Research 2011, 2011 | 114 | 2011 |
| NGcGM3 ganglioside: a privileged target for cancer vaccines LE Fernandez, MR Gabri, MD Guthmann, RE Gomez, S Gold, L Fainboim, ... Journal of Immunology Research 2010, 2010 | 101 | 2010 |
| 1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients. S Alfonso, RM Diaz, A De la Torre, E Santiesteban, F Aguirre, K Perez, ... Cancer biology & therapy 6 (12), 1847-1852, 2007 | 95 | 2007 |
| Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies AM Solares, A Santana, I Baladrón, C Valenzuela, CA González, A Díaz, ... BMC cancer 9, 1-9, 2009 | 91 | 2009 |
| Antiviral effect of high-dose ivermectin in adults with COVID-19: a proof-of-concept randomized trial A Krolewiecki, A Lifschitz, M Moragas, M Travacio, R Valentini, DF Alonso, ... EClinicalMedicine 37, 2021 | 87 | 2021 |
| Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines G A Cardama, M J Comin, L Hornos, N Gonzalez, L Defelipe, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2014 | 85 | 2014 |
| Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity Y Perera, HG Farina, J Gil, A Rodriguez, F Benavent, L Castellanos, ... Molecular cancer therapeutics 8 (5), 1189-1196, 2009 | 85 | 2009 |
| Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice Y Perera, HG Farina, I Hernández, O Mendoza, JM Serrano, O Reyes, ... International journal of cancer 122 (1), 57-62, 2008 | 83 | 2008 |
| Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma DF Alonso, EF Farías, A Urtreger, V Ladeda, MCC Vidal, EBK Joffé Journal of surgical oncology 62 (4), 288-297, 1996 | 81 | 1996 |
| Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model DF Alonso, EF Farías, V Ladeda, L Davel, L Puricelli, E Bal de Kier Joffé Breast cancer research and treatment 40, 209-223, 1996 | 76 | 1996 |
